Finance Q&A
(2006-12-07)
Listen Now:
TACOMA
(KPLU) -
Stock in the Pfizer Pharmaceutical Company plummeted this week after the company halted testing of a new cholesterol drug. Financial commentator Gerg Heberlein says it's a good example of how risky biotech stocks can be. He spoke with KPLU's Dave Meyer. 3:30
© Copyright 2012, KPLU
null
